Seres Therapeutics
MCRB
MCRB
146 hedge funds and large institutions have $1.93B invested in Seres Therapeutics in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 57 increasing their positions, 45 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.2% less ownership
Funds ownership: 4.92% → 4.71% (-0.2%)
4% less funds holding
Funds holding: 152 → 146 (-6)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
Holders
146
Holding in Top 10
1
Calls
$43.7M
Puts
$5.94M
Top Buyers
| 1 | +$15.2M | |
| 2 | +$6.54M | |
| 3 | +$6.53M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$4.15M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$3.76M |
Top Sellers
| 1 | -$51.1M | |
| 2 | -$20.1M | |
| 3 | -$16.2M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$15.7M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$9.9M |